CFGS
AMPH icon

Concourse Financial Group Securities’s Amphastar Pharmaceuticals AMPH Stock Holding History

Concourse Financial Group Securities’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,063
Closed -$38.4K – 94
2024
Q4 		$38.4K Buy
1,063
+104
+11% +$4.76K ﹤0.01% 1312
2024
Q3 		$46.5K Buy
959
+19
+2% +$834 ﹤0.01% 1209
2024
Q2 		$37.6K Buy
940
+48
+5% +$1.99K ﹤0.01% 1301
2024
Q1 		$39.2K Buy
892
+52
+6% +$2.69K ﹤0.01% 1292
2023
Q4 		$52K Buy
840
+69
+9% +$3.63K ﹤0.01% 1113
2023
Q3 		$35.5K Sell
771
-8
-1% -$436 ﹤0.01% 1215
2023
Q2 		$44.8K Sell
779
-50
-6% -$2.22K ﹤0.01% 1137
2023
Q1 		$31.1K Sell
829
-54
-6% -$1.77K ﹤0.01% 1288
2022
Q4 		$24.7K Buy
+883
New +$25.6K ﹤0.01% 1387
2022
Q3 		– Sell
-747
Closed -$24.4K – 2038
2022
Q2 		$26K Sell
747
-422
-36% -$15.1K ﹤0.01% 1349
2022
Q1 		$42K Buy
1,169
+323
+38% +$9.16K ﹤0.01% 1201
2021
Q4 		$20K Buy
846
+217
+34% +$4.44K ﹤0.01% 1625
2021
Q3 		$12K Buy
629
+128
+26% +$2.51K ﹤0.01% 1816
2021
Q2 		$10K Buy
+501
New +$9.44K ﹤0.01% 1861

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Concourse Financial Group Securities's AMPH Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 1,063 shares — an estimated $38.4K sold.

Concourse Financial Group Securities first reported a position in AMPH in Q2 2021 and held it in 14 quarters. The position peaked at $52K in Q4 2023. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,063 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $38.4K.
  • Concourse Financial Group Securities first reported a position in Amphastar Pharmaceuticals in Q2 2021 and held it in 14 quarters.
  • Concourse Financial Group Securities's Amphastar Pharmaceuticals position peaked at $52K in Q4 2023.
  • 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.